Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro

CONTEXT: Dacomitinib and poziotinib, irreversible ErbB family blockers, are often used for treatment of non-small cell lung cancer (NSCLC) in the clinic. OBJECTIVE: This study investigates the effect of dacomitinib on the pharmacokinetics of poziotinib in rats. MATERIALS AND METHODS: Twelve Sprague–...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharm Biol
Auteurs principaux: Ji, Weiping, Shen, Jiquan, Wang, Bo, Chen, Feifei, Meng, Deru, Wang, Shuanghu, Dai, Dapeng, Zhou, Yunfang, Wang, Changxiong, Zhou, Quan
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079061/
https://ncbi.nlm.nih.gov/pubmed/33899675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13880209.2021.1914114
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires